Document › Details

Uniqure N.V.. (2/28/19). "Press Release: Uniqure Announces 2018 Financial Results and Highlights Recent Company Progress". Lexington, MA & Amsterdam.

Organisations Organisation Uniqure N.V. (Nasdaq: QURE)
  Group Uniqure (Group)
  Organisation 2 Bristol-Myers Squibb Co. (BMS) (NYSE: BMY)
  Group Bristol-Myers Squibb (BMS) (Group)
Products Product AMT-061 (hemophilia B gene therapy, Uniqure)
  Product 2 AMT-130 (Huntington’s disease gene therapy, Uniqure)
Persons Person Kapusta, Matthew (Uniqure 201612– CEO before interim CEO before CFO before AngioDynamics + Smith & Nephew Orthopaedics)
  Person 2 Cantor, Maria E. (Uniqure 201606– SVP IR + Communications before Ariad Pharmaceuticals + Genzyme)
     


   
Record changed: 2019-03-06

Advertisement

[iito] Business Intelligence – The Elephants Are Coming 560x91px

More documents for Uniqure (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px




» top